Both in vitro and in vivo Zn2+ supplementation up-regulates vascular TNFAIP3 expression and suppresses NF-kB-dependent osteo-/chondrogenic signaling as well as calcification of VSMCs during hyperphosphatemia [63]. The gene discussed is NFKB1; the disease is hyperphosphatemia.